Travere Therapeutics
TVTX
TVTX
154 hedge funds and large institutions have $1.53B invested in Travere Therapeutics in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 70 increasing their positions, 55 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $1.78B → $1.53B (-$252M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
50% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 28
Holders
154
Holding in Top 10
3
Calls
$1.36M
Puts
$1.13M
Top Buyers
| 1 | +$17M | |
| 2 | +$12.2M | |
| 3 | +$12.1M | |
| 4 |
BlackRock
New York
|
+$11.1M |
| 5 |
AG
Artal Group
Luxembourg
|
+$10.5M |
Top Sellers
| 1 | -$57.5M | |
| 2 | -$43.6M | |
| 3 | -$19.7M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$10.9M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$10.3M |